New Markers for Diagnosis of Prosthetic Infections (Perimarkers)
Identification of New Biological Marker for Diagnosis of Periprosthetic Infections
Sponsor: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Listed as NCT03769337, this observational or N/A phase trial focuses on Prosthetic Joint Infections and remains ongoing. Sponsored by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio, it has been updated 8 times since 2018, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Mar 2024 — Jul 2024 [monthly]
Unknown Status
-
Dec 2021 — Mar 2024 [monthly]
Unknown Status
-
Jan 2021 — Dec 2021 [monthly]
Unknown Status
▶ Show 3 earlier versions
-
Dec 2020 — Jan 2021 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Nov 2020 — Dec 2020 [monthly]
Recruiting
-
Jan 2019 — Nov 2020 [monthly]
Recruiting
First recorded
Sep 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
For direct contact, visit the study record on ClinicalTrials.gov .